hydroxyurea,jaktinib
Not Tagged
['mpnsm', 'hydroxyurea', '#mpn']
congress|#asco23|yi zhang summarized phase 3 data on jaktinib vs hydroxyurea (hu) in pts with intermediate-2 or hr-mf. compared to hu, jaktinib showed clinical benefits in spleen &amp; symptom response, representing a new treatment option for mf pts incl those with anemia
#mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm